Aryl Hydrocarbon Receptor Pathway Augments Peritoneal Fibrosis in a Murine CKD Model Exposed to Peritoneal Dialysate
Open Access
- 5 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 5 (9) , 1238-1250
Abstract
Key Points: CKD and high glucose–containing peritoneal dialysate alter peritoneal membrane contributing to peritoneal dialysis failure, with a poorly understood mechanism. CKD milieu activates the aryl hydrocarbon receptor pathway in the subperitoneal vasculature, increasing the peritoneal fibrosis and collagen deposition in humans and mice. An aryl hydrocarbon receptor inhibitor mitigates CKD and peritoneal dialysis–mediated peritoneal fibrosis, collagen deposition, and vasculogenesis in a mouse model. Background: CKD is a proinflammatory and profibrotic condition and can independently alter the peritoneal membrane structure. Peritoneal dialysis (PD) results in profound alterations in the peritoneal membrane. The mechanisms contributing to the alterations of the peritoneal membrane structure in CKD milieu, along with PD, are poorly understood. Methods: Here, we show that human CKD induces peritoneal membrane thickening, fibrosis, and collagen deposition and activates the aryl hydrocarbon receptor (AHR) pathway in the subperitoneal vasculature. Leveraging a novel model of PD in CKD mice, we confirm these CKD-induced changes in the peritoneal membrane, which are exacerbated on exposure to the peritoneal dialysate. Peritoneal dialysate further augmented the AHR activity in endothelial cells of peritoneal microvasculature in CKD mice. Results: Treatment of CKD mice with an AHR inhibitor in peritoneal dialysate for 2 weeks resulted in a seven-fold reduction in AHR expression in the endothelial cells of subperitoneal capillaries, a five-fold decrease in subperitoneal space, and a nine-fold decrease in fibrosis and collagen deposition compared with vehicle-treated CKD mice. AHR inhibition reduced inflammation, subperitoneal neovascular areas, and its downstream target, tissue factor. The AHR inhibitor treatment normalized the peritoneal dialysate-induced proinflammatory and profibrotic cytokines, such as IL-6, monocyte chemoattractant protein-1, and macrophage inflammatory protein 1 levels, in CKD mice. Conclusions: This study uncovers the activation of the AHR-cytokine axis in the endothelial cells of subperitoneal vessels in humans and mice with CKD, which is likely to prime the peritoneal membrane to peritoneal dialysate–mediated alterations. This study supports further exploration of AHR as a potential therapeutic target to preserve the structural and functional integrity of the peritoneal membrane in PD.Keywords
Funding Information
- Division of Intramural Research (R01HL166608)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK119740)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK132784)
- Division of Intramural Research (T32HL125232)
- American Heart Association (857078)
- American Heart Association (850917)
- Division of Intramural Research (R01HL166608)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK119740)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK132784)
- Division of Intramural Research (T32HL125232)
- American Heart Association (857078)
- American Heart Association (850917)
This publication has 36 references indexed in Scilit:
- Aryl Hydrocarbon Receptor Is Activated by Glucose and Regulates the Thrombospondin-1 Gene Promoter in Endothelial CellsCirculation Research, 2008
- Peritoneal Changes after Exposure to Sterile Solutions by CatheterJournal of the American Society of Nephrology, 2007
- Reversal of liver fibrosis in aryl hydrocarbon receptor null mice by dietary vitamin A depletionHepatology, 2004
- Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial CellsNew England Journal of Medicine, 2003
- Inflammatory Cytokines, Angiogenesis, and Fibrosis in the Rat PeritoneumThe American Journal of Pathology, 2002
- Morphologic Changes in the Peritoneal Membrane of Patients with Renal DiseaseJournal of the American Society of Nephrology, 2002
- Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.2001
- Vascular and Interstitial Changes in the Peritoneum of Capd Patients with Peritoneal SclerosisPeritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 1999
- The peritoneal membrane in chronic peritoneal dialysisKidney International, 1999
- Tissue reaction to deep cuff of Tenckhoff's catheter and peritonitis.1990